|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
355,150,000 |
Market
Cap: |
2.85(B) |
Last
Volume: |
17,273,575 |
Avg
Vol: |
17,111,865 |
52
Week Range: |
$5.22 - $10.61 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 661 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
13,370 |
13,370 |
19,946 |
28,198 |
Total Sell Value |
$83,028 |
$83,028 |
$146,846 |
$216,743 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
1 |
4 |
8 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Valueact Holdings Gp, Llc |
See Remarks |
|
2015-10-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,883 |
1,883 |
|
- |
|
Valueact Holdings Gp, Llc |
Director |
|
2015-10-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
14,994,261 |
|
- |
|
Valueact Holdings Gp, Llc |
See Remarks |
|
2015-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,883 |
1,883 |
|
- |
|
Farmer Ronald Harold |
Director |
|
2015-10-21 |
4 |
B |
$158.79 |
$272,395 |
D/D |
1,500 |
15,532 |
2.39 |
- |
|
Rosiello Robert L. |
EVP, Chief Financial Officer |
|
2015-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,875 |
449,550 |
|
- |
|
Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
|
2015-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(876) |
64,118 |
|
- |
|
Provencio Norma Ann |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
196 |
143,367 |
|
- |
|
Melas Kyriazi Theo |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
140 |
221,892 |
|
- |
|
Ingram Robert Alexander |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
136 |
68,627 |
|
- |
|
Farmer Ronald Harold |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
147 |
35,691 |
|
- |
|
Farmer Ronald Harold |
Director |
|
2015-08-26 |
4 |
B |
$220.00 |
$110,000 |
D/D |
500 |
2,000 |
2.39 |
- |
|
Farmer Ronald Harold |
Director |
|
2015-08-21 |
4 |
B |
$224.97 |
$224,973 |
I/I |
1,000 |
1,500 |
2.1 |
- |
|
Valueact Holdings Gp, Llc |
See Remarks |
|
2015-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,148 |
1,148 |
|
- |
|
Valueact Holdings Gp, Llc |
Director |
|
2015-08-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,054,054 |
|
- |
|
Rosiello Robert L. |
EVP, Chief Financial Officer |
|
2015-07-31 |
4 |
B |
$257.25 |
$181,104 |
D/D |
704 |
441,675 |
2.74 |
- |
|
Rosiello Robert L. |
EVP, Chief Financial Officer |
|
2015-07-30 |
4 |
B |
$253.99 |
$1,821,362 |
D/D |
7,171 |
440,971 |
2.74 |
- |
|
Whitaker Anne Clem |
EVP, Company Group Chairman |
|
2015-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
127,455 |
|
- |
|
Rosiello Robert L. |
EVP, Chief Financial Officer |
|
2015-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,900 |
433,800 |
|
- |
|
Schiller Howard Bradley |
Director |
|
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,506 |
590,875 |
|
- |
|
Rosiello Robert L. |
EVP, Chief Financial Officer |
|
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
408,000 |
420,900 |
|
- |
|
Melas Kyriazi Theo |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
106 |
221,752 |
|
- |
|
Provencio Norma Ann |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
157 |
143,171 |
|
- |
|
Ingram Robert Alexander |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
109 |
68,491 |
|
- |
|
Farmer Ronald Harold |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
118 |
35,544 |
|
- |
|
Mirovsky Pavel |
EVP, Pres. & GM Valeant EMENA |
|
2015-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
69,525 |
|
- |
|
705 Records found
|
|
Page 24 of 29 |
|
|